WARSAW, Ind., June 11, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a limited distribution agreement with THINK Surgical, ...

Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, Persona SoluTion porous plasma spray (PPS) femur. It provides an alternative ...

"For younger and more active patients, the Oxford Cementless Partial Knee amplifies the benefits of a traditional partial knee replacement by offering knee flexion that resembles natural knee movement ...

-- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixation Together with the Clinically Proven Benefits of the Persona Knee System -- "With an ...

Zimmer Biomet and Apple teamed up to produce the “mymobility” Apple Watch and iPhone app that connects patients and surgical care teams following knee and hip replacement surgery. Zimmer Biomet is ...

WARSAW, Ind., Oct. 21, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting bold innovations across its ...

ZBH's Q3 results on Nov. 5 may show solid gains, driven by hip, knee, and S.E.T. segment growth and recent product approvals.

Biocomposites’ spacers for knee, hip, and shoulder revision surgeries are loaded with antibiotics to mitigate the risk of bone and soft tissue infection.

iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...